These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 9924810)

  • 1. Conversion of native oligomeric to a modified monomeric form of human C-reactive protein.
    Kresl JJ; Potempa LA; Anderson BE
    Int J Biochem Cell Biol; 1998 Dec; 30(12):1415-26. PubMed ID: 9924810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Native and modified C-reactive protein bind different receptors on human neutrophils.
    Heuertz RM; Schneider GP; Potempa LA; Webster RO
    Int J Biochem Cell Biol; 2005 Feb; 37(2):320-35. PubMed ID: 15474978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Native pentameric C-reactive protein displays more potent pro-atherogenic activities in human aortic endothelial cells than modified C-reactive protein.
    Devaraj S; Venugopal S; Jialal I
    Atherosclerosis; 2006 Jan; 184(1):48-52. PubMed ID: 15894319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell membranes and liposomes dissociate C-reactive protein (CRP) to form a new, biologically active structural intermediate: mCRP(m).
    Ji SR; Wu Y; Zhu L; Potempa LA; Sheng FL; Lu W; Zhao J
    FASEB J; 2007 Jan; 21(1):284-94. PubMed ID: 17116742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical staining reveals C-reactive protein existing predominantly as altered conformation forms in inflammatory lesions.
    Shi P; Li XX; Zhu W; Yang H; Dong C; Li XM
    Acta Biol Hung; 2014 Sep; 65(3):265-73. PubMed ID: 25194730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of the monomeric form of C-reactive protein to enzymatically-modified low-density lipoprotein: effects of phosphoethanolamine.
    Singh SK; Suresh MV; Hammond DJ; Rusiñol AE; Potempa LA; Agrawal A
    Clin Chim Acta; 2009 Aug; 406(1-2):151-5. PubMed ID: 19545552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-reactive protein (CRP) aptamer binds to monomeric but not pentameric form of CRP.
    Wang MS; Black JC; Knowles MK; Reed SM
    Anal Bioanal Chem; 2011 Sep; 401(4):1309-18. PubMed ID: 21725632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of pentameric symmetry of C-reactive protein is associated with promotion of neutrophil-endothelial cell adhesion.
    Zouki C; Haas B; Chan JS; Potempa LA; Filep JG
    J Immunol; 2001 Nov; 167(9):5355-61. PubMed ID: 11673552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monomeric C-Reactive Protein in Serum With Markedly Elevated CRP Levels Shares Common Calcium-Dependent Ligand Binding Properties With an
    Williams RD; Moran JA; Fryer AA; Littlejohn JR; Williams HM; Greenhough TJ; Shrive AK
    Front Immunol; 2020; 11():115. PubMed ID: 32117266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra-subunit Disulfide Determines the Conversion and Structural Stability of CRP Isoforms.
    Zhang CM; Tan YB; Zhou HH; Ge ZB; Feng JR; Lv GB; Sun ZY; Fu Y; Wang MY
    Inflammation; 2020 Apr; 43(2):466-477. PubMed ID: 31760526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-reactive protein and inflammation: conformational changes affect function.
    Wu Y; Potempa LA; El Kebir D; Filep JG
    Biol Chem; 2015 Nov; 396(11):1181-97. PubMed ID: 26040008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of C-reactive protein conformation in inflammation.
    Yao Z; Zhang Y; Wu H
    Inflamm Res; 2019 Oct; 68(10):815-823. PubMed ID: 31312858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of Conformational Changes in C-reactive Protein Alters its Bioactivity.
    Ullah N; Wu Y
    Cell Biochem Biophys; 2022 Dec; 80(4):595-608. PubMed ID: 35997934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of mouse mammary adenocarcinoma (EMT6) growth and metastases in mice by a modified form of C-reactive protein.
    Kresl JJ; Potempa LA; Anderson B; Radosevich JA
    Tumour Biol; 1999; 20(2):72-87. PubMed ID: 10050106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-reactive protein: how conformational changes influence inflammatory properties.
    Eisenhardt SU; Thiele JR; Bannasch H; Stark GB; Peter K
    Cell Cycle; 2009 Dec; 8(23):3885-92. PubMed ID: 19887916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissociation of pentameric to monomeric C-reactive protein on activated platelets localizes inflammation to atherosclerotic plaques.
    Eisenhardt SU; Habersberger J; Murphy A; Chen YC; Woollard KJ; Bassler N; Qian H; von Zur Muhlen C; Hagemeyer CE; Ahrens I; Chin-Dusting J; Bobik A; Peter K
    Circ Res; 2009 Jul; 105(2):128-37. PubMed ID: 19520972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tubular staining of modified C-reactive protein in diabetic chronic kidney disease.
    Schwedler SB; Guderian F; Dämmrich J; Potempa LA; Wanner C
    Nephrol Dial Transplant; 2003 Nov; 18(11):2300-7. PubMed ID: 14551357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational rearrangement in C-reactive protein is required for proinflammatory actions on human endothelial cells.
    Khreiss T; József L; Potempa LA; Filep JG
    Circulation; 2004 Apr; 109(16):2016-22. PubMed ID: 15051635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and functional comparison of native pentameric, denatured monomeric and biotinylated C-reactive protein.
    Taylor KE; van den Berg CW
    Immunology; 2007 Mar; 120(3):404-11. PubMed ID: 17163961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Conformational Change in C-Reactive Protein Enhances Leukocyte Recruitment and Reactive Oxygen Species Generation in Ischemia/Reperfusion Injury.
    Thiele JR; Zeller J; Kiefer J; Braig D; Kreuzaler S; Lenz Y; Potempa LA; Grahammer F; Huber TB; Huber-Lang M; Bannasch H; Stark GB; Peter K; Eisenhardt SU
    Front Immunol; 2018; 9():675. PubMed ID: 29713320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.